March 12 (Reuters) - Ultragenyx Pharmaceutical ( RARE )
said on Thursday its experimental gene therapy helped patients
in a late-stage trial to better control ammonia levels linked to
a rare inherited disorder.
(Reporting by Padmanabhan Ananthan in Bengaluru)